Cargando…

Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations

BACKGROUND: Induced pluripotent stem cells (iPSC) provide means to study the pathophysiology of genetic disorders. Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a malignant inherited ion channel disorder predominantly caused by mutations in the cardiac ryanodine receptor (RyR2). In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kujala, Kirsi, Paavola, Jere, Lahti, Anna, Larsson, Kim, Pekkanen-Mattila, Mari, Viitasalo, Matti, Lahtinen, Annukka M., Toivonen, Lauri, Kontula, Kimmo, Swan, Heikki, Laine, Mika, Silvennoinen, Olli, Aalto-Setälä, Katriina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433449/ https://www.ncbi.nlm.nih.gov/pubmed/22962621 http://dx.doi.org/10.1371/journal.pone.0044660

Ejemplares similares

Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models
por: Penttinen, Kirsi, et al.
Publicado: (2015)

Correction: Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models
por: Penttinen, Kirsi, et al.
Publicado: (2015)

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia
por: Marjamaa, Annukka, et al.
Publicado: (2009)

Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation
por: Koponen, Mikael, et al.
Publicado: (2020)

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
por: Lahti, Anna L., et al.
Publicado: (2012)

Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

KCNE1 D85N polymorphism — a sex-specific modifier in type 1 long QT syndrome?
por: Lahtinen, Annukka M, et al.
Publicado: (2011)

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients: Koponen et al. Follow-up of adult LQTS patients
por: Koponen, Mikael, et al.
Publicado: (2018)

Distinct electrophysiological and mechanical beating phenotypes of long QT syndrome type 1-specific cardiomyocytes carrying different mutations
por: Kiviaho, Anna L., et al.
Publicado: (2015)

Electrical Field Stimulation with a Novel Platform: Effect on Cardiomyocyte Gene Expression but not on Orientation
por: Kujala, Kirsi, et al.
Publicado: (2012)

Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2017)

Cardiac Differentiation of Pluripotent Stem Cells
por: Rajala, Kristiina, et al.
Publicado: (2011)

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018)

Sex differences in heart: from basics to clinics
por: Prajapati, Chandra, et al.
Publicado: (2022)

Maturation of human pluripotent stem cell derived cardiomyocytes is improved in cardiovascular construct
por: Vuorenpää, Hanna, et al.
Publicado: (2017)

Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
por: Maria Cherian, Reeja, et al.
Publicado: (2022)

p100 increases AT1R expression through interaction with AT1R 3′-UTR
por: Paukku, Kirsi, et al.
Publicado: (2008)

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023)

The Effect of Human and Mouse Fibroblast Feeder Cells on Cardiac Differentiation of Human Pluripotent Stem Cells
por: Pekkanen-Mattila, Mari, et al.
Publicado: (2012)

Culture Conditions Affect Cardiac Differentiation Potential of Human Pluripotent Stem Cells
por: Ojala, Marisa, et al.
Publicado: (2012)

Detection of genetic cardiac diseases by Ca(2+) transient profiles using machine learning methods
por: Juhola, Martti, et al.
Publicado: (2018)

Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
por: Juhola, Martti, et al.
Publicado: (2020)

Therapy Efficacy of Idiopathic Ventricular Extrasystoles: A Real Life Study
por: Lönnrot, Aliisa, et al.
Publicado: (2023)

Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mutation carriers
por: Haapalahti, Petri, et al.
Publicado: (2011)

Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
por: Ojala, Marisa, et al.
Publicado: (2016)

Human Neurons Form Axon-Mediated Functional Connections with Human Cardiomyocytes in Compartmentalized Microfluidic Chip
por: Häkli, Martta, et al.
Publicado: (2022)

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
por: Häkli, Martta, et al.
Publicado: (2022)

Polyethylene Terephthalate Textiles Enhance the Structural Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Pekkanen-Mattila, Mari, et al.
Publicado: (2019)

Human induced pluripotent stem cell-based platform for modeling cardiac ischemia
por: Häkli, Martta, et al.
Publicado: (2021)

Excitability Tuning of Axons by Afterdepolarization
por: Kamiya, Haruyuki
Publicado: (2019)

Novel Analysis Software for Detecting and Classifying Ca(2+) Transient Abnormalities in Stem Cell-Derived Cardiomyocytes
por: Penttinen, Kirsi, et al.
Publicado: (2015)

Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Gaballah, Mahmoud, et al.
Publicado: (2022)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018)

CytoSpectre: a tool for spectral analysis of oriented structures on cellular and subcellular levels
por: Kartasalo, Kimmo, et al.
Publicado: (2015)

Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities
por: Paci, Michelangelo, et al.
Publicado: (2018)

Obtaining Consent for Future Research with Induced Pluripotent Cells: Opportunities and Challenges
por: Aalto-Setälä, Katriina, et al.
Publicado: (2009)

Simultaneous recordings of action potentials and calcium transients from human induced pluripotent stem cell derived cardiomyocytes
por: Prajapati, Chandra, et al.
Publicado: (2018)

Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells
por: Shah, Disheet, et al.
Publicado: (2019)

The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Common Genetic Variants Associated with Sudden Cardiac Death: The FinSCDgen Study
por: Lahtinen, Annukka M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jfqau8tkitnktdsepq0a2l1fef